UASt regulatory sequences drive expression of an inverted repeat.
The expression of CG10333GD6705 under the control of Scer\GAL4insc-Mz1407 does not lead to any obvious changes in type II neuroblast lineages.
Expression under the control of Scer\GAL41407 may result in loss of neuroblasts in the larval brain without any change in size of the remaining neuroblasts (depending on the insertion line used).
Expression under the control of Scer\GAL41407 results in shorter neuroblast lineages (less daughter cells per neuroblast) in the larval brain compared to controls.
Expression under the control of Scer\GAL41407 results in mild defects in the shape of neuroblasts in the larval brain.
Adults expressing CG10333GD6705 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Depending on the insertion line used, expression under the control of Scer\GAL4Mef2.PR can result in early pupal lethality or late larval lethality.
Expression under the control of Scer\GAL4Mef2.PR results in grossly normal larval body wall muscles.
Expression under the control of Scer\GAL4Mef2.PR results in sarcomeres with reduced Z-lines in the larval body wall muscles.